Proceedings of the National Academy of Sciences · 1981 · 53 citations · 89 references
MedicinePharmacologyDrug MetabolismPharmacogeneticsPharmacogenomicsCytochrome P450 EnzymesCytochrome P450-mediated MetabolismInterindividual VariabilityMetabolic VariabilityMetabolite KineticsTwin StudiesCytochrome EnzymesDizygotic TwinsDrug-metabolizing Enzyme VariabilityInterindividual VariationMetabolic Rate ConstantsMonozygotic TwinsPharmacogenetic StudiesRate Constants
Adult, male, unmedicated twins received antipyrine orally under carefully controlled environmental conditions. Relative contributions of genetic and environmental factors to 2-fold interindividual variations in rate constants for formation of the three main antipyrine metabolites were compared. Heritabilities for rate constants for formation of 4-hydroxyantipyrine, N-demethylantipyrine, and 3-hydroxymethylantipyrine were 0.88, 0.85, and 0.70, respectively. These results suggest that each molecular form of cytochrome P-450 that converts antipyrine to a different metabolite exhibits genetically controlled interindividual variations in activity. Unrelated adult male subjects whose environments were also carefully controlled exhibited highly reproducible rate constants for formation of antipyrine metabolites. Because the rate constant for metabolite formation sensitively detects certain variations in the gene product, it should be used in future pharmacogenetic studies on rates of production of multiple metabolites from a single parent drug.
89